In this work, robust nanocarbons, including graphite (G), carbon nanotube (CNT), reduced graphene oxide (rGO), carbon black (CB), and acetylene black (AB), have been successfully coupled into the interfaces between g-C3N4 and NiS using a facile precipitation method. The results demonstrated that nanocarbons played trifunctional roles in boosting the photocatalytic H2 evolution over g-C3N4, which can not only act as effective H2-evolution co-catalysts but can also serve as conductive electron bridges to collect photogenerated electrons and boost the H2-evolution kinetics over the NiS co-catalysts. More interestingly, the nanocarbons can also result in the downshift of valence band of g-C3N4, thus facilitating the fast oxidation of triethanolamine and charge-carrier separation. Particularly, in all five ternary multiheterostructured systems, the g-C3N4-0.5%CB-1.0%NiS (weight ratio) and g-C3N4-0.5%AB-1.0%NiS photocatalysts exhibited the highest H2-evolution rates of 366.4 and 297.7 μmol g–1 h–1, which are 3.17 and 2.57 times higher than that of g-C3N4-1.0%NiS, respectively. Apparently, the significantly enhanced H2-evolution activity of multiheterostructured g-C3N4/carbon/NiS composite photocatalysts can be mainly ascribed to the trifunctional nanocarbons, which serve as the conductive electron bridges rather than the general co-catalysts. More importantly, it is revealed that the amorphous carbons with higher electrical conductivity and weaker electrocatalytic H2-evolution activity are more suitable interfacial bridges between g-C3N4 and NiS co-catalysts for maximizing the H2 generation. This work may give a new mechanistic insight into the development of multiheterostructured g-C3N4-based composite photocatalysts using the combination of trifunctional nanocarbon bridges and earth-abundant co-catalysts/semiconductors for various photocatalytic applications.
Human innate immunity responds to viral infection by activating the production of interferons (IFNs) and proinflammatory cytokines. The mitochondrial adaptor molecule MAVS plays a critical role in innate immune response to viral infection. In this study, we show that TRIM21 (tripartite motif-containing protein 21) interacts with MAVS to positively regulate innate immunity. Under viral infection, TRIM21 is upregulated through the IFN/JAK/STAT signaling pathway. Knockdown of TRIM21 dramatically impairs innate immune response to viral infection. Moreover, TRIM21 interacts with MAVS and catalyzes its K27-linked polyubiquitination, thereby promoting the recruitment of TBK1 to MAVS. Specifically, the PRY-SPRY domain of TRIM21 is the key domain for its interaction with MAVS, while the RING domain of TRIM21 facilitates the polyubiquitination chains of MAVS. In addition, the MAVS-mediated innate immune response is enhanced by both the PRY-SPRY and RING domains of TRIM21. Mutation analyses of all the lysine residues of MAVS further revealed that Lys325 of MAVS is catalyzed by TRIM21 for the K27-linked polyubiquitination. Overall, this study reveals a novel mechanism by which TRIM21 promotes the K27-linked polyubiquitination of MAVS to positively regulate innate immune response, thereby inhibiting viral infection. IMPORTANCE Activation of innate immunity is essential for host cells to restrict the spread of invading viruses and other pathogens. MAVS plays a critical role in innate immune response to RNA viral infection. In this study, we demonstrated that TRIM21 targets MAVS to positively regulate innate immunity. Notably, TRIM21 targets and catalyzes K27-linked polyubiquitination of MAVS and then promotes the recruitment of TBK1 to MAVS, leading to upregulation of innate immunity. Our study outlines a novel mechanism by which the IFN signaling pathway blocks RNA virus to escape immune elimination.
RNA viruses represent a major global health threat, and the visualization of their RNA genome in infected cells is essential for virological research and clinical diagnosis. Due to the lack of chemical toolkits for the live-cell imaging of viral RNA genomes, especially native viral genomes without labeling and genetic modification, studies on native virus infection at the single-live-cell level are challenging. Herein, taking hepatitis C virus (HCV) as a representative RNA virus, we propose that the innate noncanonical G-quadruplex (G4) structure of viral RNA can serve as a specific imaging target and report a new benzothiazole-based G4-targeted fluorescence light-up probe, ThT-NE, for the direct visualization of the native RNA genome of HCV in living host cells. We demonstrate the use of the ThT-NE probe for several previously intractable applications, including the sensitive detection of individual virus-infected cells by small-molecule staining, real-time monitoring of the subcellular distribution of the viral RNA genome in live cells, and continuous live-cell tracking of the infection and propagation of clinically isolated native HCV. The fluorogenic-probe-based viral RNA light-up system opens up a promising chemical strategy for cutting-edge live-cell viral analysis, providing a potentially powerful tool for viral biology, medical diagnosis, and drug development.
The ability to harness innate immunity is a promising solution for improving cancer immunotherapy. Interferon (IFN) induces expression of IFN-stimulated genes (ISGs) by activating the JAK-STAT signaling pathway to promote innate immunity and inhibit malignant tumor growth, but the functions and mechanisms of most ISGs in cancer regulation are unknown. As an innate immune effector, ISG12a promotes the innate immune response to viral infection. In this study, ISG12a was found to be expressed at low levels in gastrointestinal cancer, represented by hepatocellular cancer (HCC) and gastric cancer (GC), and it identified as a tumor suppressor that affects clinical prognosis. ISG12a silencing accelerated the malignant transformation and epithelial-mesenchymal transition of cancer cells. Mechanistically, ISG12a promoted β-catenin proteasomal degradation by inhibiting the degradation of ubiquitinated Axin, thereby suppressing the canonical Wnt/β-catenin signaling pathway. Notably, β-catenin was identified as a transcription factor for PD-L1. Inhibition of Wnt/β-catenin signaling by ISG12a suppressed expression of the immune checkpoint PD-L1, rendering cancer cells sensitive to NK cell-mediated killing. This study reveals a mechanism underlying the anticancer effects of IFN. Some ISGs, as represented by ISG12a, may be useful in cancer therapy and prevention. The identified interrelations among innate immunity, Wnt/β-catenin signaling, and cancer immunity may provide new insight into strategies that will improve the efficiency of immunotherapy.
Engineering the formulation of non-aqueous liquid electrolytes is a viable strategy to produce high-energy lithium metal batteries. However, when the lithium metal anode is combined with a Ni-rich layered cathode, the (electro)chemical stability of both electrodes could be compromised. To circumvent this issue, we report a combination of aluminum ethoxide (0.4 wt.%) and fluoroethylene carbonate (5 vol.%) as additives in a conventional LiPF6-containing carbonate-based electrolyte solution. This electrolyte formulation enables the formation of mechanically robust and ionically conductive interphases on both electrodes’ surfaces. In particular, the alumina formed at the interphases prevents the formation of dendritic structures on the lithium metal anode and mitigate the stress-induced cracking and phase transformation in the Ni-rich layered cathode. By coupling a thin (i.e., about 40 μm) lithium metal anode with a high-loading (i.e., 21.5 mg cm−2) LiNi0.8Co0.1Mn0.1O2-based cathode in coin cell configuration and lean electrolyte conditions, the engineered electrolyte allows a specific discharge capacity retention of 80.3% after 130 cycles at 60 mA g−1 and 30 °C which results in calculated specific cell energy of about 350 Wh kg−1.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.